speb/financial-data huggingface dataset:
Stock screener scorecard for 6763.T (annual, report date 2026-03-31)
Altman Z-score: 4.812596728392479 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 4.945818272176003%
Earnings yield: 0.043381893480194215%
Return on net tangible assets: -3.9034375886261565%
Capitalized R&D asset: 7315053.723572532
ROCI (R&D adjusted): 3.5660210606818032%
Rosenberg metric: -1.1458030475127836
Free cash flow margin: -7.6537877934022%
Revenue growth: -3.791577867387848%
Rule of 40 score: -11.44536566079005
Market cap: 27248113664 (Large Cap ($10B-$200B))
P/E ratio: 0.12198360467716828
Debt to equity: 0.0016
Free cash flow (dilution adjusted): -8263263.263263263
Operating income: 7244826.076076076
Net income: 8308958.958958959
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 7575.T (annual, report date 2026-03-31)
Altman Z-score: 6.878544858171493 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 25.551053484602914%
Earnings yield: 0.0902222494733772%
Return on net tangible assets: 14.155137571894915%
Capitalized R&D asset: 37335677.6430574
ROCI (R&D adjusted): 17.68076708734855%
Rosenberg metric: -0.4440505921565201
Free cash flow margin: 10.471894165948605%
Revenue growth: -2.132757426212651%
Rule of 40 score: 8.339136739735954
Market cap: 96883335168 (Large Cap ($10B-$200B))
P/E ratio: 0.06426663776404903
Debt to equity: 0.04650000000000001
Free cash flow (dilution adjusted): 38776276.276276276
Operating income: 78903903.9039039
Net income: 58495995.995996
Long score: 9 | Short score: 0
Recommendation: Long
Stock screener scorecard for 8195.HK (annual, report date 2026-03-31)
Altman Z-score: 7.104033886097309 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 16.258934863586028%
Earnings yield: 2.0260007096886543%
Return on net tangible assets: 16.242777974295482%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 11.167108543702364%
Free cash flow margin: 19.038339978000426%
Revenue growth: 16.198996689729096%
Rule of 40 score: 35.23733666772952
Market cap: 533502528 (Small Cap ($300M-$2B))
P/E ratio: 2.2480867346938775
Debt to equity: 0.0416
Free cash flow (dilution adjusted): 9757780.612244897
Operating income: 7209821.428571429
Net income: 5652040.816326531
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 9042.T (annual, report date 2026-03-31)
Altman Z-score: 1.1265959598362982 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 5.648381927416979%
Earnings yield: 0.03083958599060999%
Return on net tangible assets: 14.64155810019789%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.308477164430537%
Free cash flow margin: 4.294037586850418%
Revenue growth: 1.77991888301018%
Rule of 40 score: 6.073956469860598
Market cap: 1104452517888 (Mega Cap (>= $200B))
P/E ratio: 0.08621220742432864
Debt to equity: 1.1941
Free cash flow (dilution adjusted): 323317067.0670671
Operating income: 795401651.6516516
Net income: 522190940.9409409
Long score: 5 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 9766.T (quarterly, report date 2026-03-31)
Altman Z-score: 9.729581797657634 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 6.913377526404347%
Earnings yield: 0.009716676474159898%
Return on net tangible assets: 4.828339888396849%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.410126040088522%
Free cash flow margin: 29.407708112642812%
Revenue growth: 7.378353429689044%
Rule of 40 score: 36.78606154233186
Market cap: 2483394707456 (Mega Cap (>= $200B))
P/E ratio: 0.16384222499622744
Debt to equity: 0.0707
Free cash flow (dilution adjusted): 258783783.78378376
Operating income: 213357107.1071071
Net income: 160573073.07307306
Long score: 8 | Short score: 2
Recommendation: Long
Stock screener scorecard for 9766.T (annual, report date 2026-03-31)
Altman Z-score: 10.64965738879771 (Safe Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 27.547892720306518%
Earnings yield: 0.038718261817144016%
Return on net tangible assets: 15.433980584432563%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 21.557852321311007%
Free cash flow margin: 16.20168652783095%
Revenue growth: 9.608544656202172%
Rule of 40 score: 25.81023118403312
Market cap: 2483394707456 (Mega Cap (>= $200B))
P/E ratio: 0.16384222499622744
Debt to equity: 0.0707
Free cash flow (dilution adjusted): 500400400.4004004
Operating income: 850168918.9189188
Net income: 625706956.956957
Long score: 11 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 9996.T (annual, report date 2026-03-31)
Altman Z-score: 3.887208591580464 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 9.755601588355042%
Earnings yield: 0.10044528619451037%
Return on net tangible assets: 2.193435998320729%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.684159816677805%
Free cash flow margin: 1.041300726545401%
Revenue growth: -3.2000477565011813%
Rule of 40 score: -2.15874702995578
Market cap: 18265069568 (Large Cap ($10B-$200B))
P/E ratio: 0.09640706405666799
Debt to equity: 0.0258
Free cash flow (dilution adjusted): 3310335.335335335
Operating income: 9832657.657657657
Net income: 7836498.998998999
Long score: 7 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for A (quarterly, report date 2026-04-30)
Altman Z-score: 4.602807133299603 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 8.68713259307642%
Earnings yield: 0.9762280868298048%
Return on net tangible assets: 14.791573285522187%
Capitalized R&D asset: 243660000
ROCI (R&D adjusted): 3.6625524095246895%
Rosenberg metric: 0.37606837606837606
Free cash flow margin: 9.209809264305177%
Revenue growth: 2.057842046718576%
Rule of 40 score: 11.267651311023753
Market cap: 39136595968 (Large Cap ($10B-$200B))
P/E ratio: 23.20523138832998
Debt to equity: 0.49729999999999996
Free cash flow (dilution adjusted): 169000000
Operating income: 399000000
Net income: 339000000
Long score: 9 | Short score: 0
Recommendation: Long
Stock screener scorecard for ALBKK.PA (annual, report date 2025-12-31)
Altman Z-score: 3.1315933481819322 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 7.129651576202893%
Earnings yield: 3.6534392247712897%
Return on net tangible assets: 18.21635672865427%
Capitalized R&D asset: 6363863.970588235
ROCI (R&D adjusted): 5.090791863584726%
Rosenberg metric: 1.1028153393337028
Free cash flow margin: 10.439571284764028%
Revenue growth: 20.017174753112936%
Rule of 40 score: 30.456746037876965
Market cap: 90624200 (Micro Cap ($50M-$300M))
P/E ratio: 26.666666666666668
Debt to equity: 0.35729999999999995
Free cash flow (dilution adjusted): 6222352.94117647
Operating income: 3538823.529411765
Net income: 4415294.117647059
Long score: 7 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for BXC (quarterly, report date 2026-03-31)
Altman Z-score: 1.7999157267820418 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0.6609292333112663%
Earnings yield: 0.9128896753293918%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.5509227655601098%
Free cash flow margin: -8.422444859733014%
Revenue growth: 1.8656171973332352%
Rule of 40 score: -6.556827662399779
Market cap: 454569696 (Small Cap ($300M-$2B))
Debt to equity: 1.084
Free cash flow (dilution adjusted): -62916000
Operating income: 7328000
Net income: -1458000
Long score: 0 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for CTAC.AS (annual, report date 2025-12-31)
Altman Z-score: 2.865444925399526 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 36.937742031575816%
Earnings yield: 13.125654152435123%
Return on net tangible assets: 117.02634529147981%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 12.624398686655297%
Free cash flow margin: -0.7175301688821009%
Revenue growth: 14.192939435387588%
Rule of 40 score: 13.475409266505487
Market cap: 43154520 (Nano Cap (< $50M))
P/E ratio: 13.882352941176471
Debt to equity: 0.24350000000000002
Free cash flow (dilution adjusted): -1061176.4705882354
Operating income: 5835294.117647059
Net income: 4234117.647058824
Long score: 10 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for CVE.TO (quarterly, report date 2026-03-31)
Altman Z-score: 2.1156776671786828 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 4.541341803830975%
Earnings yield: 1.9179549557310358%
Return on net tangible assets: 6.319878398919099%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.101324802670468%
Free cash flow margin: 6.004947897143715%
Revenue growth: -5.67461657019626%
Rule of 40 score: 0.33033132694745504
Market cap: 77017022464 (Large Cap ($10B-$200B))
P/E ratio: 10.521941012926712
Debt to equity: 0.4227
Free cash flow (dilution adjusted): 576258992.8057555
Operating income: 1697122302.1582735
Net income: 1129496402.877698
Long score: 7 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for CXM (quarterly, report date 2026-04-30)
Altman Z-score: 1.4960387627803002 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 3.3166639458139406%
Earnings yield: 1.0660973412005657%
Return on net tangible assets: 1.85549415195338%
Capitalized R&D asset: 48478380
ROCI (R&D adjusted): 1.4993043424318302%
Rosenberg metric: -0.07088977528533628
Free cash flow margin: 20.87397883168777%
Revenue growth: -0.5045513889896279%
Rule of 40 score: 20.36942744269814
Market cap: 1332761728 (Small Cap ($300M-$2B))
P/E ratio: 41
Debt to equity: 0.0897
Free cash flow (dilution adjusted): 45814000
Operating income: 9955000
Net income: 4181000
Long score: 5 | Short score: 8
Recommendation: Neutral
Stock screener scorecard for FDC.NS (quarterly, report date 2026-03-31)
Altman Z-score: 9.918171435873012 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 4.945078895189472%
Earnings yield: 0.015684151633978568%
Return on net tangible assets: 4.745593075307036%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.601157387248192%
Revenue growth: 19.71848385370782%
Rule of 40 score: 19.71848385370782
Market cap: 67232423936 (Large Cap ($10B-$200B))
P/E ratio: 0.1958292217938225
Debt to equity: 0.0062
Operating income: 9750498.09241204
Net income: 10957683.340398474
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for FDC.NS (annual, report date 2026-03-31)
Altman Z-score: 10.681848615001494 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 15.417747014365155%
Earnings yield: 0.04889998464187459%
Return on net tangible assets: 7.279506260647743%
Capitalized R&D asset: 1373182.9651978812
ROCI (R&D adjusted): 10.782241897079716%
Rosenberg metric: -5.897880235419161
Free cash flow margin: 0.639780164585442%
Revenue growth: -6.646122099399545%
Rule of 40 score: -6.0063419348141025
Market cap: 67232423936 (Large Cap ($10B-$200B))
P/E ratio: 0.1958292217938225
Debt to equity: 0.0062
Free cash flow (dilution adjusted): 1471937.261551505
Operating income: 30400063.586265367
Net income: 29824247.562526494
Long score: 8 | Short score: 0
Recommendation: Long
Stock screener scorecard for GENO.OL (quarterly, report date 2026-03-31)
Altman Z-score: 3.983320469977648 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 5.1388346770394495%
Earnings yield: 0.1711018702431109%
Return on net tangible assets: 2.938004232717962%
Capitalized R&D asset: 716471.0386543546
ROCI (R&D adjusted): 4.104743795236138%
Rosenberg metric: 8.73058987479007
Free cash flow margin: 5.788003641806706%
Revenue growth: 2.1443472204133656%
Rule of 40 score: 7.932350862220072
Market cap: 3590893824 (Mid Cap ($2B-$10B))
P/E ratio: 3.249268716894616
Debt to equity: 0.1399
Free cash flow (dilution adjusted): 1927440.9044193216
Operating income: 5101130.524152107
Net income: 2665467.6258992804
Long score: 8 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for GODAVARIB.NS (annual, report date 2026-03-31)
Altman Z-score: 1.831460108227263 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 6.535807428765813%
Earnings yield: 0.039952450478773556%
Return on net tangible assets: -14.002420699072177%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.165950501575926%
Free cash flow margin: 0.12050649752160852%
Revenue growth: -3.642569146597744%
Rule of 40 score: -3.5220626490761355
Market cap: 14272978944 (Large Cap ($10B-$200B))
P/E ratio: 4.450155246736804
Debt to equity: 0.6733
Free cash flow (dilution adjusted): 253878.76218736754
Operating income: 7696640.52564646
Net income: 373887.2403560831
Long score: 6 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for GODAVARIB.NS (quarterly, report date 2026-03-31)
Altman Z-score: 1.1371199177789908 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 6.505209711355533%
Earnings yield: 0.03976541103446291%
Return on net tangible assets: 8.693864851285507%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.137084288323889%
Revenue growth: 16.703303703929492%
Rule of 40 score: 16.703303703929492
Market cap: 14272978944 (Large Cap ($10B-$200B))
P/E ratio: 4.450155246736804
Debt to equity: 0.6733
Operating income: 7660608.308605341
Net income: 5604578.211106401
Long score: 1 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for GUJTHEM.NS (quarterly, report date 2026-03-31)
Altman Z-score: 11.159984804272387 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 3.6509870466142216%
Earnings yield: 0.003975877757975948%
Return on net tangible assets: 5.189797689800297%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.6111674813442027%
Revenue growth: -2.9672608642109997%
Rule of 40 score: -2.9672608642109997
Market cap: 39353131008 (Large Cap ($10B-$200B))
P/E ratio: 0.558033792893468
Debt to equity: 0.5623
Operating income: 1623717.676981772
Net income: 1154217.88893599
Long score: 3 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for GUJTHEM.NS (annual, report date 2026-03-31)
Altman Z-score: 11.711494835724835 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 14.919734474535856%
Earnings yield: 0.016247398222687247%
Return on net tangible assets: -39.256014052110025%
Capitalized R&D asset: 423616.6243989392
ROCI (R&D adjusted): 13.980530721437423%
Rosenberg metric: 1.8622270078024443
Free cash flow margin: -74.6321374382775%
Revenue growth: -0.3162185585200458%
Rule of 40 score: -74.94835599679755
Market cap: 39353131008 (Large Cap ($10B-$200B))
P/E ratio: 0.558033792893468
Debt to equity: 0.5623
Free cash flow (dilution adjusted): -13115419.66935142
Operating income: 6635311.5727002965
Net income: 4947700.296735905
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for JOY.TO (quarterly, report date 2026-03-31)
Altman Z-score: 0.4827599439820985 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 1.0204058297143457%
Earnings yield: 0.8958108843634315%
Return on net tangible assets: -3.7446543681448876%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.8637644799603543%
Free cash flow margin: -7.509761476056566%
Revenue growth: 2.730302526003162%
Rule of 40 score: -4.779458950053404
Market cap: 306363744 (Small Cap ($300M-$2B))
P/E ratio: 23.063901819720694
Debt to equity: 0.1484
Free cash flow (dilution adjusted): -2670503.5971223023
Operating income: 3210071.9424460432
Net income: -4207913.669064748
Long score: 3 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for KANSAINER.NS (annual, report date 2026-03-31)
Altman Z-score: 7.392571329071071 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 11.241457618644604%
Earnings yield: 0.05941194443185876%
Return on net tangible assets: 9.091469103879538%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.582424623899199%
Free cash flow margin: 8.415548478370614%
Revenue growth: -6.604327410809269%
Rule of 40 score: 1.8112210675613447
Market cap: 156247965696 (Large Cap ($10B-$200B))
P/E ratio: 0.2394933089699918
Debt to equity: 0.0453
Free cash flow (dilution adjusted): 71550445.10385756
Operating income: 79109792.28486647
Net income: 62470326.40949555
Long score: 8 | Short score: 0
Recommendation: Long
Stock screener scorecard for KANSAINER.NS (quarterly, report date 2026-03-31)
Altman Z-score: 6.472040650431953 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 2.3432252779191676%
Earnings yield: 0.012384120878787408%
Return on net tangible assets: 2.6018339195485365%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.205853166164821%
Revenue growth: -6.221791165434578%
Rule of 40 score: -6.221791165434578
Market cap: 156247965696 (Large Cap ($10B-$200B))
P/E ratio: 0.2394933089699918
Debt to equity: 0.0453
Operating income: 16490038.15175922
Net income: 11898050.021195421
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for KRISHIVAL.NS (quarterly, report date 2026-03-31)
Altman Z-score: 12.932227474784339 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 1.4554446881153609%
Earnings yield: 0.0034226385122646183%
Return on net tangible assets: 4.241417110473671%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.3078780862292383%
Revenue growth: 30.496369764187914%
Rule of 40 score: 30.496369764187914
Market cap: 9932247040 (Mid Cap ($2B-$10B))
P/E ratio: 0.3664603868791896
Debt to equity: 0.1809
Operating income: 303136.9224247563
Net income: 591511.2335735481
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for KRISHIVAL.NS (annual, report date 2026-03-31)
Altman Z-score: 13.919161857300308 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 10.1370267286077%
Earnings yield: 0.023838335021934217%
Return on net tangible assets: -3.5426719327536604%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 9.109240101067465%
Free cash flow margin: -18.754279528920385%
Revenue growth: 31.193508561883316%
Rule of 40 score: 12.439229032962931
Market cap: 9932247040 (Mid Cap ($2B-$10B))
P/E ratio: 0.3664603868791896
Debt to equity: 0.1809
Free cash flow (dilution adjusted): -5816935.142009325
Operating income: 2111318.3552352693
Net income: 2352278.507842306
Long score: 5 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for MHO (quarterly, report date 2026-03-31)
Altman Z-score: 3.7190630186818057 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 2.0307626384978232%
Earnings yield: 2.1112805567316593%
Return on net tangible assets: 2.2696644638487222%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.9069913784889865%
Free cash flow margin: 14.270772352116362%
Revenue growth: -19.750458683610724%
Rule of 40 score: -5.479686331494362
Market cap: 3860775936 (Mid Cap ($2B-$10B))
P/E ratio: 9.206766917293233
Debt to equity: 0.3169
Free cash flow (dilution adjusted): 131392000
Operating income: 86065000
Net income: 67832000
Long score: 8 | Short score: 2
Recommendation: Long
Stock screener scorecard for MJS.V (quarterly, report date 2026-03-31)
Altman Z-score: 1.2531463761346848 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 4.614566349748089%
Earnings yield: 16.321652454034144%
Return on net tangible assets: 5.436882833043444%
Capitalized R&D asset: 500106.2724360658
ROCI (R&D adjusted): 4.3714894238355635%
Rosenberg metric: 2.8734376041719085
Free cash flow margin: 14.434952679448577%
Revenue growth: -9.28510238999456%
Rule of 40 score: 5.149850289454017
Market cap: 93839800 (Micro Cap ($50M-$300M))
P/E ratio: 10.79136690647482
Debt to equity: 0.1549
Free cash flow (dilution adjusted): 2445877.6978417267
Operating income: 9321535.971223023
Net income: 5002145.323741008
Long score: 7 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for MLHOT.PA (annual, report date 2025-12-31)
Altman Z-score: 3.338344180540649 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 13.498506139398483%
Earnings yield: 22.03132326296904%
Return on net tangible assets: 11.183630135145508%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 11.121966911313887%
Free cash flow margin: 7.636915347388765%
Revenue growth: 9.836622662553525%
Rule of 40 score: 17.47353800994229
Market cap: 49496164 (Nano Cap (< $50M))
P/E ratio: 13.950007483909594
Debt to equity: 0.1887056608922198
Free cash flow (dilution adjusted): 2242057.6470588236
Operating income: 6402369.4117647065
Net income: 4753541.176470588
Long score: 10 | Short score: 1
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for MUNJALSHOW.NS (annual, report date 2026-03-31)
Altman Z-score: 3.9687136394680236 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 2.115020560466248%
Earnings yield: 0.04438209778046139%
Return on net tangible assets: 4.774162603398986%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.789925353414768%
Free cash flow margin: -2.0684928747173434%
Revenue growth: -4.636791061487737%
Rule of 40 score: -6.705283936205081
Market cap: 5432121344 (Mid Cap ($2B-$10B))
P/E ratio: 0.2130595513597736
Debt to equity: 0
Free cash flow (dilution adjusted): -2883573.5481136073
Operating income: 1310110.2161933023
Net income: 2317899.533700721
Long score: 4 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for PASHUPATI.NS (quarterly, report date 2026-03-31)
Altman Z-score: 6.760995346689408 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 2.3179251090709565%
Earnings yield: 0.003772718567001275%
Return on net tangible assets: 2.277296202068829%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.2238751436607482%
Revenue growth: 1.9796749660455137%
Rule of 40 score: 1.9796749660455137
Market cap: 13746284544 (Large Cap ($10B-$200B))
P/E ratio: 14.727338498176225
Debt to equity: 0.601
Operating income: 523124.20517168293
Net income: 182354.81136074607
Long score: 3 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for PASHUPATI.NS (annual, report date 2026-03-31)
Altman Z-score: 8.580198347087904 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 8.055261678727748%
Earnings yield: 0.013110965137942137%
Return on net tangible assets: 10.972227723526453%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.728418900550945%
Free cash flow margin: 5.315172559482452%
Revenue growth: -2.19137904370566%
Rule of 40 score: 3.123793515776792
Market cap: 13746284544 (Large Cap ($10B-$200B))
P/E ratio: 14.727338498176225
Debt to equity: 0.601
Free cash flow (dilution adjusted): 3874353.539635439
Operating income: 1817963.1199660874
Net income: 1104154.3026706232
Long score: 8 | Short score: 0
Recommendation: Long
Stock screener scorecard for PNGJL.NS (annual, report date 2026-03-31)
Altman Z-score: 4.655300960271668 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 29.617740366649087%
Earnings yield: 0.05913248049181722%
Return on net tangible assets: 22.79401617972212%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 26.472681238315342%
Free cash flow margin: -7.5385947254224455%
Revenue growth: 26.539736887037517%
Rule of 40 score: 19.00114216161507
Market cap: 87803289600 (Large Cap ($10B-$200B))
P/E ratio: 0.18555548977597813
Debt to equity: 0.885
Free cash flow (dilution adjusted): -85796629.92793557
Operating income: 59214921.57693938
Net income: 43431538.78762187
Long score: 7 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for PNGJL.NS (quarterly, report date 2026-03-31)
Altman Z-score: 2.91318016581024 (Grey Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 6.27236562075116%
Earnings yield: 0.012522918126605765%
Return on net tangible assets: 5.5569159129652546%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.606313433528816%
Revenue growth: 2.098087234709121%
Rule of 40 score: 2.098087234709121
Market cap: 87803289600 (Large Cap ($10B-$200B))
P/E ratio: 0.18555548977597813
Debt to equity: 0.885
Operating income: 12540377.278507842
Net income: 9565069.944891904
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for PROSTARM.NS (quarterly, report date 2026-03-31)
Altman Z-score: 2.435120327106326 (Grey Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 4.031569374886938%
Earnings yield: 0.01280596118701219%
Return on net tangible assets: 3.1642398176250106%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.326531298325825%
Revenue growth: -38.081947125541696%
Rule of 40 score: -38.081947125541696
Market cap: 7281020928 (Mid Cap ($2B-$10B))
P/E ratio: 0.20922026701009172
Debt to equity: 0.3243
Operating income: 1048654.0907164053
Net income: 842147.0962272149
Long score: 3 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for PROSTARM.NS (annual, report date 2026-03-31)
Altman Z-score: 3.162404673295773 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 17.551185542396443%
Earnings yield: 0.05574995242349799%
Return on net tangible assets: 4.941397301016136%
Capitalized R&D asset: 245.35315985130111
ROCI (R&D adjusted): 14.480947423586867%
Free cash flow margin: -18.841326199837262%
Revenue growth: -0.2675429186786132%
Rule of 40 score: -19.108869118515877
Market cap: 7281020928 (Mid Cap ($2B-$10B))
P/E ratio: 0.20922026701009172
Debt to equity: 0.3243
Free cash flow (dilution adjusted): -7702797.795676134
Operating income: 4565250.105977109
Net income: 3497774.480712166
Long score: 5 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for PRVA (quarterly, report date 2026-03-31)
Altman Z-score: 3.7508851705390356 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 1.9876009265830243%
Earnings yield: 0.25990512072170535%
Return on net tangible assets: 2.115708782113167%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.9088971998324749%
Free cash flow margin: -11.821868784642467%
Revenue growth: 11.581139487742368%
Rule of 40 score: -0.24072929690009914
Market cap: 3213315584 (Mid Cap ($2B-$10B))
P/E ratio: 121
Debt to equity: 0.011200000000000002
Free cash flow (dilution adjusted): -71386000
Operating income: 7422000
Net income: 3710000
Long score: 5 | Short score: 8
Recommendation: Neutral
Stock screener scorecard for SHL.AX (annual, report date 2025-06-30)
Altman Z-score: 1.9529568046227503 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 24.36280761406208%
Earnings yield: 3.6882930967637355%
Return on net tangible assets: -71.29253143085214%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.544289453842503%
Free cash flow margin: 8.671162613290546%
Revenue growth: 5.555882784637759%
Rule of 40 score: 14.227045397928304
Market cap: 10487729152 (Large Cap ($10B-$200B))
P/E ratio: 15.062120944473882
Debt to equity: 0.6822
Free cash flow (dilution adjusted): 545160130.7189542
Operating income: 591574509.8039216
Net income: 355504575.1633987
Long score: 8 | Short score: 3
Recommendation: Long
Stock screener scorecard for SQU.DE (annual, report date 2025-12-31)
Altman Z-score: 1.1643436871476505 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 110.64143524207424%
Earnings yield: 11.565595354901571%
Return on net tangible assets: -19.49412279815432%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 12.010457795326007%
Free cash flow margin: 10.164856939050487%
Revenue growth: 17.494955765947548%
Rule of 40 score: 27.659812704998036
Market cap: 65428418560 (Large Cap ($10B-$200B))
P/E ratio: 15.863333786170356
Debt to equity: 1.1876
Free cash flow (dilution adjusted): 9052941176.470589
Operating income: 10592941176.470589
Net income: 6205882352.941176
Long score: 8 | Short score: 4
Recommendation: Long
Stock screener scorecard for SRAD.L (annual, report date 2025-12-31)
Altman Z-score: 4.516551325453266 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 23.114553291779075%
Earnings yield: 15.391222176581218%
Return on net tangible assets: 14.211905794505311%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 22.172231724548226%
Free cash flow margin: 10.080901866250832%
Revenue growth: 4.0234113877244555%
Rule of 40 score: 14.104313253975288
Market cap: 203764096 (Micro Cap ($50M-$300M))
P/E ratio: 1.8243243243243243
Debt to equity: 1.4423
Free cash flow (dilution adjusted): 38089189.18918919
Operating income: 40290540.54054054
Net income: 1140540.5405405406
Long score: 11 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for SYENS.BR (annual, report date 2025-12-31)
Altman Z-score: 2.139166776647888 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 9.68229954614221%
Earnings yield: 6.912002910782666%
Capitalized R&D asset: 704462990.1960785
ROCI (R&D adjusted): 4.780871175444041%
Rosenberg metric: -0.2308559351884474
Free cash flow margin: 4.0710336739822415%
Revenue growth: 4.599826586957512%
Rule of 40 score: 8.670860260939754
Market cap: 6732529664 (Mid Cap ($2B-$10B))
Debt to equity: 0.4168
Free cash flow (dilution adjusted): 285882352.9411765
Operating income: 602352941.1764706
Net income: -70588235.29411764
Long score: 6 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for SYENS.BR (quarterly, report date 2025-12-31)
Altman Z-score: 1.6075082231012958 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0.907715582450832%
Earnings yield: 0.6480002728858749%
Return on net tangible assets: -1.223380154055279%
Capitalized R&D asset: 175294117.64705884
ROCI (R&D adjusted): 0.49608096041273925%
Rosenberg metric: -1.3287671232876705
Free cash flow margin: 9.03179190751445%
Revenue growth: -11.168164313222071%
Rule of 40 score: -2.136372405707622
Market cap: 6732529664 (Mid Cap ($2B-$10B))
Debt to equity: 0.4168
Free cash flow (dilution adjusted): 147058823.52941176
Operating income: 56470588.23529412
Net income: -172941176.47058824
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for TASTYBITE.NS (quarterly, report date 2026-03-31)
Altman Z-score: 12.06421953939688 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0.875453565580852%
Earnings yield: 0.0014557454916152269%
Return on net tangible assets: 4.133125288130786%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.8382573071771843%
Revenue growth: -36.747796872362414%
Rule of 40 score: -36.747796872362414
Market cap: 23091433472 (Large Cap ($10B-$200B))
P/E ratio: 0.500562849665987
Debt to equity: 0.1225
Operating income: 338278.93175074185
Net income: 636710.4705383637
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for TASTYBITE.NS (annual, report date 2026-03-31)
Altman Z-score: 13.175191807222 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 8.982449788953158%
Earnings yield: 0.014936441289439316%
Return on net tangible assets: 17.11999243471991%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 8.600803592531317%
Free cash flow margin: 9.237981532799544%
Revenue growth: -10.224479570843279%
Rule of 40 score: -0.9864980380437345
Market cap: 23091433472 (Large Cap ($10B-$200B))
P/E ratio: 0.500562849665987
Debt to equity: 0.1225
Free cash flow (dilution adjusted): 5362865.621025858
Operating income: 3470856.2950402712
Net income: 3741203.8999576094
Long score: 9 | Short score: 0
Recommendation: Long
Stock screener scorecard for TTEK (quarterly, report date 2026-03-31)
Altman Z-score: 3.0692119623136556 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 22.465660256125446%
Earnings yield: 1.4421320757922618%
Return on net tangible assets: -21.482289997350122%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.195468326152865%
Free cash flow margin: 12.282353828236857%
Revenue growth: 0.7841984102925421%
Rule of 40 score: 13.0665522385294
Market cap: 8229528064 (Mid Cap ($2B-$10B))
P/E ratio: 17.98802395209581
Debt to equity: 0.5954
Free cash flow (dilution adjusted): 149864000
Operating income: 131465000
Net income: 93798000
Long score: 7 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for URC.TO (quarterly, report date 2026-01-31)
Altman Z-score: 263.1484473929402 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0.7676395869218123%
Earnings yield: 0.45930969397354654%
Return on net tangible assets: 0.5256859111976611%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.7676395869218123%
Free cash flow margin: 47.20288115246098%
Revenue growth: 42039.114724480576%
Rule of 40 score: 42086.317605633034
Market cap: 611290816 (Small Cap ($300M-$2B))
P/E ratio: 116.48148148148147
Debt to equity: 0.0004
Free cash flow (dilution adjusted): 5825185.185185185
Operating income: 2168888.8888888885
Net income: 1453333.3333333333
Long score: 8 | Short score: 3
Recommendation: Long
Stock screener scorecard for 1171.HK (annual, report date 2025-12-31)
Altman Z-score: 0.6230030197036649 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 8.38663570452511%
Earnings yield: 1.0053204630824186%
Return on net tangible assets: 14.917322802174896%
Capitalized R&D asset: 941719690.0649838
ROCI (R&D adjusted): 6.390373667058478%
Rosenberg metric: -3.4196362037093646
Free cash flow margin: 0.6068396125408662%
Revenue growth: -3.5283110799903294%
Rule of 40 score: -2.9214714674494635
Market cap: 34102191516.70952 (Large Cap ($10B-$200B))
P/E ratio: 2.3972239762883754
Debt to equity: 0.7803869052327812
Free cash flow (dilution adjusted): 125644285.7142857
Operating income: 2808193571.428571
Net income: 2032243000
Long score: 5 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 4045.T (annual, report date 2025-12-31)
Altman Z-score: 3.1436495566268223 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 7.377620558705717%
Earnings yield: 0.04901331963948925%
Return on net tangible assets: -1.6579082652653228%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.866900537378634%
Free cash flow margin: -5.621888708166987%
Revenue growth: -2.792530870480104%
Rule of 40 score: -8.414419578647092
Market cap: 170801932299.27264 (Large Cap ($10B-$200B))
P/E ratio: 13.302331175955814
Debt to equity: 0.1010081364063665
Free cash flow (dilution adjusted): -58340259.574196026
Operating income: 90671951.92123266
Net income: 82091937.85563584
Long score: 5 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 4430.T (annual, report date 2025-05-31)
Altman Z-score: 2.891439526965347 (Grey Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 19.031485683392344%
Earnings yield: 0.10524794720335959%
Return on net tangible assets: 23.842133663156236%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 13.31046429136539%
Free cash flow margin: 6.966495600692505%
Revenue growth: 33.41319206759554%
Rule of 40 score: 40.37968766828804
Market cap: 7186938839.57 (Mid Cap ($2B-$10B))
P/E ratio: 8.836023595186928
Debt to equity: 0.4108869687059037
Free cash flow (dilution adjusted): 5174767.005146752
Operating income: 7793051.884824037
Net income: 5657031.576018917
Long score: 10 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 4631.T (annual, report date 2025-12-31)
Altman Z-score: 1.680571520084347 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 8.526725251960876%
Earnings yield: 0.04102070643448146%
Return on net tangible assets: 12.519450017125802%
Capitalized R&D asset: 211792768.5783214
ROCI (R&D adjusted): 5.548177760314257%
Rosenberg metric: 0.4054648358844732
Free cash flow margin: 2.9476503382456087%
Revenue growth: -1.403311770005512%
Rule of 40 score: 1.5443385682400967
Market cap: 341961101539.9782 (Mega Cap (>= $200B))
P/E ratio: 10.296311620497958
Debt to equity: 0.9336428682025245
Free cash flow (dilution adjusted): 198292948.02122626
Operating income: 333687104.4050892
Net income: 212339364.49076146
Long score: 6 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for A (annual, report date 2025-10-31)
Altman Z-score: 5.412788270183329 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 34.63700234192038%
Earnings yield: 3.618649975993186%
Return on net tangible assets: 64.94788809654416%
Capitalized R&D asset: 934660000
ROCI (R&D adjusted): 12.924235755500678%
Rosenberg metric: 0.2254697286012526
Free cash flow margin: 14.73805411629246%
Revenue growth: 6.728110599078341%
Rule of 40 score: 21.4661647153708
Market cap: 41091023532.560005 (Large Cap ($10B-$200B))
P/E ratio: 31.53570493673062
Debt to equity: 0.4975522919448153
Free cash flow (dilution adjusted): 1024000000
Operating income: 1479000000
Net income: 1303000000
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for BXC (annual, report date 2025-12-31)
Altman Z-score: 3.3959999673121177 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 2.914431473670705%
Earnings yield: 4.046587789809584%
Return on net tangible assets: 2.846636411308857%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.427727952167414%
Free cash flow margin: 0.7156669396929912%
Revenue growth: 0.12231545444321588%
Rule of 40 score: 0.8379823941362071
Market cap: 478072524.85 (Small Cap ($300M-$2B))
P/E ratio: 2182.979565525114
Debt to equity: 1.091797542583608
Free cash flow (dilution adjusted): 21599000
Operating income: 32483000
Net income: 219000
Long score: 4 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 245A.T (annual, report date 2025-08-31)
Altman Z-score: 3.8712842169312482 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 1.0136283293535082%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 15.107955743454863%
Free cash flow margin: 0.9786967694044586%
Revenue growth: 18.91322176266409%
Rule of 40 score: 19.891918532068548
Market cap: 7826446000 (Mid Cap ($2B-$10B))
P/E ratio: 28.73281764548235
Debt to equity: 1.476319035561191
Free cash flow (dilution adjusted): 515559.6430274542
Operating income: 3343722.3244090197
Net income: 1855623.6800871994
Long score: 6 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3616.HK (quarterly, report date 2024-12-31)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 293505154.63917524 (Micro Cap ($50M-$300M))
Debt to equity: 0.6772143005012325
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3698.T (annual, report date 2025-09-30)
Altman Z-score: 4.78744921446567 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 14.28538919836029%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 12.98232853442191%
Free cash flow margin: 24.048023146871454%
Revenue growth: 4.617084044012204%
Rule of 40 score: 28.66510719088366
Market cap: 7298629030.339999 (Mid Cap ($2B-$10B))
P/E ratio: 17.00063829668192
Debt to equity: 0.24401867523725324
Free cash flow (dilution adjusted): 5580868.102288022
Operating income: 3730693.1359353974
Net income: 2889064.6029609693
Long score: 9 | Short score: 0
Recommendation: Long
Stock screener scorecard for 4881.T (annual, report date 2025-12-31)
Altman Z-score: -0.260816517891681 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -128.487729329983%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -112.60370471808233%
Free cash flow margin: -446394.58598726115%
Revenue growth: -68.48356243206955%
Rule of 40 score: -446463.0695496932
Market cap: 3686857115.226972 (Mid Cap ($2B-$10B))
Debt to equity: 0
Free cash flow (dilution adjusted): -8961568.953391727
Operating income: -10540681.54210089
Net income: -12221258.231570872
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for AEON (annual, report date 2025-12-31)
Altman Z-score: -128.50133337251037 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 13595270
ROCI (R&D adjusted): -149.28425191047896%
Rule of 40 score: 0
Market cap: 48574691.00000001 (Nano Cap (< $50M))
Debt to equity: -0.6495902011739692
Free cash flow (dilution adjusted): -22629000
Operating income: -16302000
Net income: -39222000
Long score: 1 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for BMNR (annual, report date 2025-08-31)
Altman Z-score: 154.34487503726595 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 4.0064549994668%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -4.127822451944726%
Free cash flow margin: -125.33223954060706%
Revenue growth: 84.13897280966768%
Rule of 40 score: -41.193266730939385
Market cap: 26306703042.34 (Large Cap ($10B-$200B))
P/E ratio: 75.46884344733014
Debt to equity: 0
Free cash flow (dilution adjusted): -7639000
Operating income: -362633000
Net income: 348577000
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for BUC.L (annual, report date 2025-09-30)
Altman Z-score: 1.0190429243935633 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.1897810218978107%
Free cash flow margin: -2.5223069637605304%
Revenue growth: 9.118738767748596%
Rule of 40 score: 6.596431803988065
Market cap: 76891.91279999999 (Nano Cap (< $50M))
Debt to equity: 1.2594887683965923
Free cash flow (dilution adjusted): -683783.7837837838
Operating income: 162162.16216216216
Net income: -41891.89189189189
Long score: 2 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for CBLU.V (annual, report date 2025-12-31)
Altman Z-score: -16.161989901292323 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 403386.84851462406
ROCI (R&D adjusted): -303.07129797284404%
Rosenberg metric: 0.7168443812345352
Free cash flow margin: -98.06516809925968%
Revenue growth: 22.90056312291616%
Rule of 40 score: -75.16460497634353
Market cap: 6038155.14 (Nano Cap (< $50M))
Debt to equity: -0.8710073390666578
Free cash flow (dilution adjusted): -2324734.306569343
Operating income: -2104372.2627737224
Net income: -2836731.3868613136
Long score: 1 | Short score: 13
Recommendation: Short
Stock screener scorecard for CGN.DE (annual, report date 2025-12-31)
Altman Z-score: 2.637462701917282 (Grey Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -24.711214629693746%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 8.027407779320122%
Free cash flow margin: 3.063311107378384%
Revenue growth: 11.255829825958367%
Rule of 40 score: 14.319140933336751
Market cap: 72217346292 (Large Cap ($10B-$200B))
P/E ratio: 11.484946929389313
Debt to equity: 0.7513731671204088
Free cash flow (dilution adjusted): 8389000000
Operating income: 8154000000
Net income: 6288000000
Long score: 6 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for COR (annual, report date 2025-09-30)
Altman Z-score: 4.881687983018311 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -12.345783476080124%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 20.957440001432104%
Free cash flow margin: 0.9520272499772269%
Revenue growth: 9.312270535076268%
Rule of 40 score: 10.264297785053495
Market cap: 60463740616.2 (Large Cap ($10B-$200B))
P/E ratio: 38.56563381638383
Debt to equity: 4.384888542915771
Free cash flow (dilution adjusted): 3059176000
Operating income: 3933622000
Net income: 1567814000
Long score: 5 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for DOS.V (annual, report date 2025-12-31)
Altman Z-score: 10.594525110299536 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -35.05774998533751%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -3.9986328492352246%
Rule of 40 score: 0
Market cap: 4282711.98 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -187437.95620437956
Operating income: -72159.12408759123
Net income: -604070.802919708
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for HBOR3.SA (annual, report date 2025-12-31)
Altman Z-score: 0.5799001389985532 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 5.72096150334501%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.9675904913711413%
Free cash flow margin: 0.6007291339894476%
Revenue growth: 0.17574370418017926%
Rule of 40 score: 0.7764728381696269
Market cap: 323762884.11576307 (Small Cap ($300M-$2B))
P/E ratio: 3.51809106050075
Debt to equity: 0.669172220043255
Free cash flow (dilution adjusted): 1237043.795620438
Operating income: 18788503.649635036
Net income: 16793430.656934306
Long score: 3 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for HPHA.DE (annual, report date 2025-11-30)
Altman Z-score: -15.536625027658237 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 70678173.93461472
ROCI (R&D adjusted): -41.76008781302512%
Rosenberg metric: -0.17212159163088744
Free cash flow margin: -2185.1615510603447%
Revenue growth: -76.49494071247945%
Rule of 40 score: -2261.656491772824
Market cap: 136142362.47 (Micro Cap ($50M-$300M))
Debt to equity: -0.010467000600744285
Free cash flow (dilution adjusted): -37030941.86046512
Operating income: -54703206.97674419
Net income: -49164419.76744186
Long score: 1 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for LSBK (annual, report date 2025-12-31)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 5.168774137066769%
Capitalized R&D asset: 0
Free cash flow margin: 24.714419139305985%
Revenue growth: 14.244675175442195%
Rule of 40 score: 38.95909431474818
Market cap: 113931827.10000001 (Micro Cap ($50M-$300M))
P/E ratio: 15.673658976475444
Debt to equity: 0
Free cash flow (dilution adjusted): 6880000
Net income: 7269000
Long score: 5 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for NOMA (annual, report date 2025-12-31)
Altman Z-score: 4.472127710987378 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -38.498505450244416%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -27.591197020450487%
Free cash flow margin: -128.7979694990997%
Revenue growth: 11388.348909657321%
Rule of 40 score: 11259.550940158222
Market cap: 66668819.84 (Micro Cap ($50M-$300M))
Debt to equity: 0.4965349761926557
Free cash flow (dilution adjusted): -1187440
Operating income: -2733312
Net income: -2767318
Long score: 5 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for OACC (annual, report date 2025-12-31)
Altman Z-score: 15.032338255904804 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 3.7418233551320728%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.5924753093251984%
Rule of 40 score: 0
Market cap: 209304245.8 (Micro Cap ($50M-$300M))
P/E ratio: 28.715777167894302
Debt to equity: 6.0700216318958485e-05
Free cash flow (dilution adjusted): -422079
Operating income: -1195687
Net income: 7288824
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for PGE.V (annual, report date 2025-03-31)
Altman Z-score: 41.45062392143959 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -78.53802028632809%
Capitalized R&D asset: 582927.6886298886
ROCI (R&D adjusted): -68.10787475220253%
Rule of 40 score: 0
Market cap: 55957995.900000006 (Micro Cap ($50M-$300M))
Debt to equity: 0
Free cash flow (dilution adjusted): -3399641.258741259
Operating income: -2839404.8951048953
Net income: -2649000.6993006994
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for PSM.DE (annual, report date 2025-12-31)
Altman Z-score: 0.7823214444458444 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.4551820728291317%
Free cash flow margin: 0.6256800870511425%
Revenue growth: 5.992281007373594%
Rule of 40 score: 6.617961094424737
Market cap: 1117496419.2 (Small Cap ($300M-$2B))
Debt to equity: 1.6737468139337293
Free cash flow (dilution adjusted): 27058823.529411767
Operating income: -15294117.647058824
Net income: -198823529.4117647
Long score: 2 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for QCRH (annual, report date 2025-12-31)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 7.6541263995957065%
Capitalized R&D asset: 0
Free cash flow margin: 97.43903759799389%
Revenue growth: 6.509490048537228%
Rule of 40 score: 103.94852764653112
Market cap: 1372128563.79 (Small Cap ($300M-$2B))
P/E ratio: 10.78768309660833
Debt to equity: 0.5716845378675568
Free cash flow (dilution adjusted): 350877000
Net income: 127194000
Long score: 4 | Short score: 0
Recommendation: Neutral